Production (Stage)
Ardent Health Partners, Inc.
ARDT
$14.62
-$0.18-1.22%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.50B | 1.61B | 1.45B | 1.47B | 1.44B |
| Total Other Revenue | -- | -- | -- | -- | 22.95M |
| Total Revenue | 1.50B | 1.61B | 1.45B | 1.47B | 1.44B |
| Cost of Revenue | 657.65M | 653.97M | 635.22M | 624.06M | 621.51M |
| Gross Profit | 839.58M | 952.32M | 814.59M | 846.86M | 817.54M |
| SG&A Expenses | 605.52M | 615.53M | 589.74M | 593.25M | 584.53M |
| Depreciation & Amortization | 36.20M | 37.85M | 36.77M | 36.31M | 35.35M |
| Other Operating Expenses | 130.77M | 141.37M | 117.70M | 115.32M | 121.83M |
| Total Operating Expenses | 1.43B | 1.45B | 1.38B | 1.37B | 1.36B |
| Operating Income | 67.09M | 157.57M | 70.38M | 101.99M | 75.83M |
| Income Before Tax | 74.20M | 167.25M | 57.07M | 82.18M | 56.56M |
| Income Tax Expenses | 15.23M | 26.36M | 11.06M | 15.22M | 10.71M |
| Earnings from Continuing Operations | 58.97M | 140.89M | 46.01M | 66.96M | 45.85M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -17.58M | -26.69M | -19.68M | -24.19M | -18.80M |
| Net Income | 41.38M | 114.20M | 26.32M | 42.77M | 27.05M |
| EBIT | 67.09M | 157.57M | 70.38M | 101.99M | 75.83M |
| EBITDA | 103.29M | 195.43M | 107.15M | 138.30M | 111.18M |
| EPS Basic | 0.30 | 0.82 | 0.19 | 0.34 | 0.21 |
| Normalized Basic EPS | 0.21 | 0.46 | 0.12 | 0.22 | 0.13 |
| EPS Diluted | 0.29 | 0.81 | 0.19 | 0.34 | 0.21 |
| Normalized Diluted EPS | 0.20 | 0.46 | 0.12 | 0.22 | 0.13 |
| Average Basic Shares Outstanding | 140.06M | 140.04M | 137.11M | 126.12M | 126.12M |
| Average Diluted Shares Outstanding | 140.70M | 140.83M | 137.54M | 126.12M | 126.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |